ArticleG3 (Bethesda, Md.)2026
Alternative lengthening of telomeres is dependent on RAD52 and RAD51 gene function in the budding yeast Naumovozyma castellii.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Telomerase is a specialized ribonucleoprotein enzyme responsible for elongation of telomeres, the DNA ends of eukaryotic chromosomes. In the absence of telomerase activity, telomeres progressively shorten, eventually triggering a DNA damage response that leads the cell to halt the cell cycle, a process known as replicative senescence. In budding yeast, the telomerase core enzyme consists of Est2, the catalytic subunit that acts as a reverse transcriptase, in complex with the noncoding telomerase RNA template (TLC1). Saccharomyces cerevisiae cells lacking any of these 2 components exhibit a severe growth crisis, which only few cells manage to survive by activating alternative lengthening of telomeres (ALT) pathways. In contrast, telomerase-deficient strains of the budding yeast Naumovozyma castellii can bypass senescence, by rapidly activating an ALT mechanism that allows the cells to maintain short and stable telomeres. The process involves a spreading of the telomere-adjacent TelKO element, leading to homogenization of the subtelomeric regions. In this study, we investigated the genetic requirements of the ALT mechanism in N. castellii, by analyzing deletion mutants of several genes involved in DNA recombination. By applying a quantitative growth assay, we demonstrate that the establishment of the ALT cells requires RAD52 and RAD51 gene function, while the RAD50 and RAD59 genes are not essential. This implies that the N. castellii ALT mechanism is dependent on homologous recombination with a similar genetic basis as the type I pathway in S. cerevisiae and shows that subtelomeric regions are playing a key role in the effective activation of ALT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.